The hardware and bandwidth for this mirror is donated by dogado GmbH, the Webhosting and Full Service-Cloud Provider. Check out our Wordpress Tutorial.
If you wish to report a bug, or if you are interested in having us mirror your free-software or open-source project, please feel free to contact us at mirror[@]dogado.de.
Implements ordered beta regression models, which are for modeling continuous variables with upper and lower bounds, such as survey sliders, dose-response relationships and indexes. For more information, see Kubinec (2022) <doi:10.31235/osf.io/2sx6y>. The package is a front-end to the R package 'brms', which facilitates a range of regression specifications, including hierarchical, dynamic and multivariate modeling.
Version: | 0.7.2 |
Depends: | R (≥ 3.5), brms (≥ 2.18.0), stats |
Imports: | transformr, dplyr, ggplot2 (≥ 3.4.0), gganimate, tidyr |
Suggests: | rmarkdown, knitr, gt, modelsummary (≥ 1.4.1), marginaleffects (≥ 0.10.0), haven, stringr, Hmisc, collapse, ggthemes, glmmTMB, mice, bayestestR |
Published: | 2023-08-10 |
DOI: | 10.32614/CRAN.package.ordbetareg |
Author: | Robert Kubinec [aut, cre] |
Maintainer: | Robert Kubinec <rmk7 at nyu.edu> |
BugReports: | https://github.com/saudiwin/ordbetareg_pack/issues |
License: | MIT + file LICENSE |
NeedsCompilation: | no |
Materials: | NEWS |
In views: | MixedModels |
CRAN checks: | ordbetareg results |
Reference manual: | ordbetareg.pdf |
Vignettes: |
package_introduction |
Package source: | ordbetareg_0.7.2.tar.gz |
Windows binaries: | r-devel: ordbetareg_0.7.2.zip, r-release: ordbetareg_0.7.2.zip, r-oldrel: ordbetareg_0.7.2.zip |
macOS binaries: | r-release (arm64): ordbetareg_0.7.2.tgz, r-oldrel (arm64): ordbetareg_0.7.2.tgz, r-release (x86_64): ordbetareg_0.7.2.tgz, r-oldrel (x86_64): ordbetareg_0.7.2.tgz |
Old sources: | ordbetareg archive |
Reverse suggests: | bayestestR, marginaleffects |
Please use the canonical form https://CRAN.R-project.org/package=ordbetareg to link to this page.
These binaries (installable software) and packages are in development.
They may not be fully stable and should be used with caution. We make no claims about them.
Health stats visible at Monitor.